Phase I trial of exisulind (sulindac sulfone, FGN-1) as a chemopreventive agent in patients with familial adenomatous polyposis.
暂无分享，去创建一个
G. T. Budd | E. Hawk | G. Kelloff | G. Stoner | L. Rybicki | R. Ganapathi | P. Elson | G. Budd | W. Hayton | B. Deyoung | L. Kresty | L. Rybicki | J. Church | D. McLain | B. H. Kemmenoe | K. Chan | R. V. van Stolk | G. Kelloff | B. Fryer | K. Provencher | D. Mclain | Paul Elson | Gary D. Stoner | Ram Ganapathi | Rosalind van Stolk | William L. Hayton | Kenneth Chan | Barry R. DeYoung | Laura Kresty | Brian H. Kemmenoe | James M. Church | Kim Provencher | Denise McLain | Ernest T. Hawk | Ben Fryer | R. V. Stolk | K. Chan